#8: TheMachine: Pharmaceutical Stock : SPPI Stock News : New Data from Satraplatin Phase 3 Trial in Second-Line Castrate-Refractory Prostate Cancer Presented at 2009 ASCO Annual Meeting
SPARC Trial Analyses Demonstrate Pain At Baseline, Pain
... |
June 11, 2009
12:56:52 AM |
#7: TheMachine: SPPI Stock News : ZEVALIN® Produced 83 Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT) Orbital Lymphoma Study
Study Results Published in the January 15, 2009 Annals of Oncology
... |
January 22, 2009
07:19:59 AM |
#6: TheMachine: Spectrum Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2008
Recently Launched FDA Approved Drug –
FUSILEV™
... |
September 20, 2008
01:21:46 AM |
#5: TheMachine: FDA Approves New Drug Application (NDA) for LEVOleucovorin, Spectrum's First Proprietary Oncology Drug
Proprietary Drug Levoleucovorin For Injection (formerly known as
... |
March 8, 2008
09:09:55 AM |
#4: TheMachine: Spectrum Pharmaceuticals Receives Approval from Canadian Authorities to Expand EOquin(R) Registrational, Phase 3 Clinical Trials into Canada
Spectrum Pharmaceuticals, Inc., (Nasdaq:SPPI) today announced that the... |
March 8, 2008
09:09:34 AM |
#3: TheMachine: Spectrum Pharmaceuticals to Present at the Roth Capital Partners 20th Annual Orange County Growth Stock Conference
Spectrum Pharmaceuticals, Inc., (Nasdaq:SPPI) announced today that
... |
March 8, 2008
09:09:08 AM |
#2: FastFun: Profile
Spectrum Pharmaceuticals, Inc. is engaged in the business of acquiring, developing... |
November 27, 2007
11:00:54 PM |
#1: Jason: SPPI, Spectrum Pharmaceuticals to Present at the Friedman, Billings, Ramsey 11th Annual Growth Conference
Spectrum Pharmaceuticals, Inc., (Nasdaq: SPPI StocksForum) announced today that... |
June 3, 2007
09:18:04 PM |
